Adult patients with cancer who were admitted to The University of Texas MD Anderson Cancer Center with nonhypovolemic hyponatremia ( @-@ mmol/L ) were randomized to receive either tolvaptan or placebo in a double-blind , placebo-controlled , adaptive , randomized trial .